jan 1, 1997 - FDA approves first-ever targeted cancer drug, rituximab
Description:
FDA approves the first molecularly targeted cancer drug to treat patients with B-cell non-Hodgkin lymphoma that no longer responds to other treatments.
Added to timeline:
Cancer Dates
Date:
